Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
MONTREAL, May 01, 2024 (GLOBE NEWSWIRE) -- Velan Inc. (TSX: VLN) announced today that, on Thursday, May 16, 2024, it will release its fourth quarter and annual results for the year ended February...
-
MONTRÉAL, 01 mai 2024 (GLOBE NEWSWIRE) -- Velan Inc. (TSX: VLN) annonce aujourd’hui que le jeudi 16 mai 2024, elle communiquera ses résultats financiers pour le 4e trimestre ainsi que ses...
-
Fort Collins, Colorado, April 20, 2024 (GLOBE NEWSWIRE) -- The emphasis on energy efficiency is indeed paramount across various sectors, and steam systems present a significant area for...
-
NEWARK, Del, April 18, 2024 (GLOBE NEWSWIRE) -- The global ESD valve market is estimated to be valued at US$ 315.9 million in 2024 and US$ 581.9 million by 2034. The global ESD valve sales are...
-
NEW YORK, April 05, 2024 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases,...
-
Austin, TX, USA, April 05, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Ball Valves Market Size, Trends and Insights By Material (Stainless Steel, Cast...
-
ISELIN, N.J., March 18, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve the first approval for an ophthalmic formulation of...
-
LOS ALTOS, Calif., March 14, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY) (the “Company” or “Unicycive”), a clinical-stage biotechnology company developing therapies for...
-
REDWOOD CITY, Calif., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper”), a clinical-stage biotechnology company focused on developing novel antibody therapies...
-
MONTREAL, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Velan Inc. (“Velan”) (TSX: VLN) today announces that its board of directors has appointed Mr. James Mannebach as CEO of Velan. Mr. Mannebach is the Chair...